☰

Michel Roberge - Publications

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Biochemistry
Website:
http://cbd.lsi.ubc.ca/current-membership/dr-michel-roberge/
Tree Info Similar researchers PubMed Report error

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Persaud R, Li SC, Chao JD, Forestieri R, Donohue E, Balgi AD, Zheng X, Chao JT, Yashiroda Y, Yoshimura M, Loewen CJR, Gingras AC, Boone C, Av-Gay Y, Roberge M, et al. Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik1. Cell Chemical Biology. PMID 34520745 DOI: 10.1016/j.chembiol.2021.07.017  0.757
2019 Hamada K, Omura N, Taguchi A, Baradaran-Heravi A, Kotake M, Arai M, Takayama K, Taniguchi A, Roberge M, Hayashi Y. New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations. Acs Medicinal Chemistry Letters. 10: 1450-1456. PMID 31620232 DOI: 10.1021/Acsmedchemlett.9B00273  0.331
2019 Ferguson MW, Gerak CAN, Chow CCT, Rastelli EJ, Elmore KE, Stahl F, Hosseini-Farahabadi S, Baradaran-Heravi A, Coltart DM, Roberge M. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418. Plos One. 14: e0216423. PMID 31120902 DOI: 10.1371/Journal.Pone.0216423  0.367
2019 Rabea SM, Baradaran-Heravi A, Balgi AD, Krause A, Hosseini Farahabadi S, Roberge M, Grierson DS. 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides. Acs Medicinal Chemistry Letters. 10: 726-731. PMID 31097990 DOI: 10.1021/Acsmedchemlett.8B00610  0.363
2019 Law S, Du X, Panwar P, Honson NS, Pfeifer T, Roberge M, Brömme D. Identification of substrate-specific inhibitors of cathepsin K through high-throughput screening. The Biochemical Journal. PMID 30622151 DOI: 10.1042/Bcj20180851  0.348
2018 Ng MY, Zhang H, Weil A, Singh V, Jamiolkowski R, Baradaran-Heravi A, Roberge M, Jacobson A, Friesen W, Welch E, Goldman YE, Cooperman BS. New Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery. Acs Medicinal Chemistry Letters. 9: 1285-1291. PMID 30613341 DOI: 10.1021/Acsmedchemlett.8B00472  0.31
2017 Morris EJ, Kawamura E, Gillespie JA, Balgi A, Kannan N, Muller WJ, Roberge M, Dedhar S. Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1. Nature Communications. 8: 15289. PMID 28474672 DOI: 10.1038/Ncomms15289  0.334
2017 Baradaran-Heravi A, Niesser J, Balgi AD, Choi K, Zimmerman C, South AP, Anderson HJ, Strynadka NC, Bally MB, Roberge M. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 28289221 DOI: 10.1073/Pnas.1620982114  0.315
2017 Robichaud A, Roberge M, Balgi A, McCormick C, Weeks A. Csig-18. Raloxifene Sensitizes Glioblastoma Cells To Hypoxia-Induced Death Through Inhibition Of Rna Stress Granule Dissolution Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.212  0.306
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Roberge M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.323
2014 Donohue E, Balgi AD, Komatsu M, Roberge M. Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin. Plos One. 9: e114964. PMID 25494214 DOI: 10.1371/Journal.Pone.0114964  0.752
2014 Yang YH, Vilin YY, Roberge M, Kurata HT, Johnson JD. Multiparameter screening reveals a role for Na+ channels in cytokine-induced β-cell death. Molecular Endocrinology (Baltimore, Md.). 28: 406-17. PMID 24438339 DOI: 10.1210/Me.2013-1257  0.301
2014 Donohue E, Balgi AD, Komatsu M, Roberge M. Effect of verteporfin-induced high-MW p62 on its association with polyubiquitinated proteins and LC3. Plos One. DOI: 10.1371/Journal.Pone.0114964.G006  0.745
2013 Dragowska WH, Weppler SA, Wang JC, Wong LY, Kapanen AI, Rawji JS, Warburton C, Qadir MA, Donohue E, Roberge M, Gorski SM, Gelmon KA, Bally MB. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer. Plos One. 8: e76503. PMID 24146879 DOI: 10.1371/Journal.Pone.0076503  0.759
2013 Donohue E, Thomas A, Maurer N, Manisali I, Zeisser-Labouebe M, Zisman N, Anderson HJ, Ng SS, Webb M, Bally M, Roberge M. The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model. Journal of Cancer. 4: 585-96. PMID 24069069 DOI: 10.7150/Jca.7030  0.767
2013 Forestieri R, Donohue E, Balgi A, Roberge M, Andersen RJ. Synthesis of clionamine B, an autophagy stimulating aminosteroid isolated from the sponge Cliona celata. Organic Letters. 15: 3918-21. PMID 23869546 DOI: 10.1021/Ol4016783  0.744
2013 Austin P, Freeman SA, Gray CA, Gold MR, Vogl AW, Andersen RJ, Roberge M, Roskelley CD. The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an E-cadherin-independent manner. Molecular Cancer Research : McR. 11: 530-40. PMID 23399642 DOI: 10.1158/1541-7786.Mcr-12-0385  0.315
2013 Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer TA, Shimizu Y, Anderson HJ, Pinto LH, Lamb RA, DeGrado WF, Roberge M. Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay. Plos One. 8: e55271. PMID 23383318 DOI: 10.1371/Journal.Pone.0055271  0.318
2013 Towle KM, Chaytor JL, Liu H, Austin P, Roberge M, Roskelley CD, Vederas JC. Synthesis and biological studies of neopetrosiamides as inhibitors of cancer cell invasion. Organic & Biomolecular Chemistry. 11: 1476-81. PMID 23334605 DOI: 10.1039/C3Ob27238A  0.34
2013 Donohue E, Thomas A, Maurer N, Manisali I, Zeisser-Labouebe M, Zisman N, Anderson HJ, Webb M, Bally M, Roberge M. Abstract B11: The early autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B11  0.781
2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Roberge M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496  0.613
2012 Lam KK, Zheng X, Forestieri R, Balgi AD, Nodwell M, Vollett S, Anderson HJ, Andersen RJ, Av-Gay Y, Roberge M. Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. Plos Pathogens. 8: e1002691. PMID 22589723 DOI: 10.1371/Journal.Ppat.1002691  0.334
2012 Fonseca BD, Diering GH, Bidinosti MA, Dalal K, Alain T, Balgi AD, Forestieri R, Nodwell M, Rajadurai CV, Gunaratnam C, Tee AR, Duong F, Andersen RJ, Orlowski J, Numata M, ... ... Roberge M, et al. Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling. The Journal of Biological Chemistry. 287: 17530-45. PMID 22474287 DOI: 10.1074/Jbc.M112.359638  0.362
2012 Rocha DD, Balgi A, Maia AI, Pessoa OD, Silveira ER, Costa-Lotufo LV, Roberge M, Pessoa C. Cell cycle arrest through inhibition of tubulin polymerization by withaphysalin F, a bioactive compound isolated from Acnistus arborescens. Investigational New Drugs. 30: 959-66. PMID 21416228 DOI: 10.1007/S10637-011-9649-X  0.384
2012 Kawamura E, Fielding A, Kannan N, Eaves C, Roberge M, Dedhar S. Abstract 3887: A screen for new cancer specific drugs that target centrosome clustering Cancer Research. 72: 3887-3887. DOI: 10.1158/1538-7445.Am2012-3887  0.39
2011 Balgi AD, Diering GH, Donohue E, Lam KK, Fonseca BD, Zimmerman C, Numata M, Roberge M. Regulation of mTORC1 signaling by pH. Plos One. 6: e21549. PMID 21738705 DOI: 10.1371/Journal.Pone.0021549  0.737
2011 Riffell JL, Jänicke RU, Roberge M. Caspase-3-dependent mitotic checkpoint inactivation by the small-molecule inducers of mitotic slippage SU6656 and geraldol. Molecular Cancer Therapeutics. 10: 839-49. PMID 21441410 DOI: 10.1158/1535-7163.Mct-10-0909  0.802
2011 Donohue E, Tovey A, Vogl AW, Arns S, Sternberg E, Young RN, Roberge M. Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. The Journal of Biological Chemistry. 286: 7290-300. PMID 21193398 DOI: 10.1074/Jbc.M110.139915  0.795
2010 Carr G, Williams DE, Díaz-Marrero AR, Patrick BO, Bottriell H, Balgi AD, Donohue E, Roberge M, Andersen RJ. Bafilomycins produced in culture by Streptomyces spp. isolated from marine habitats are potent inhibitors of autophagy. Journal of Natural Products. 73: 422-7. PMID 20028134 DOI: 10.1021/Np900632R  0.75
2009 Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, Nabi IR, Roberge M. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. Plos One. 4: e7124. PMID 19771169 DOI: 10.1371/Journal.Pone.0007124  0.767
2009 Riffell JL, Zimmerman C, Khong A, McHardy LM, Roberge M. Effects of chemical manipulation of mitotic arrest and slippage on cancer cell survival and proliferation. Cell Cycle (Georgetown, Tex.). 8: 3025-38. PMID 19713760 DOI: 10.4161/Cc.8.18.9623  0.787
2009 Balgi AD, Roberge M. Screening for chemical inhibitors of heterologous proteins expressed in yeast using a simple growth-restoration assay. Methods in Molecular Biology (Clifton, N.J.). 486: 125-37. PMID 19347620 DOI: 10.1007/978-1-60327-545-3_9  0.349
2009 Kemmer D, McHardy LM, Hoon S, Rebérioux D, Giaever G, Nislow C, Roskelley CD, Roberge M. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. Bmc Microbiology. 9: 9. PMID 19144191 DOI: 10.1186/1471-2180-9-9  0.771
2009 Nodwell M, Pereira A, Riffell JL, Zimmerman C, Patrick BO, Roberge M, Andersen RJ. Synthetic approaches to the microtubule-stabilizing sponge alkaloid ceratamine A and desbromo analogues. The Journal of Organic Chemistry. 74: 995-1006. PMID 19128042 DOI: 10.1021/Jo802322S  0.753
2008 Schriemer DC, Kemmer D, Roberge M. Design of phenotypic screens for bioactive chemicals and identification of their targets by genetic and proteomic approaches. Combinatorial Chemistry & High Throughput Screening. 11: 610-6. PMID 18795880 DOI: 10.2174/138620708785739934  0.319
2008 Roberge M. Defining drug targets in yeast haploinsufficiency screens: application to human translational pharmacology. Science Signaling. 1: pt5. PMID 18728306 DOI: 10.1126/Scisignal.134Pt5  0.307
2008 Keyzers RA, Daoust J, Davies-Coleman MT, Van Soest R, Balgi A, Donohue E, Roberge M, Andersen RJ. Autophagy-modulating aminosteroids isolated from the sponge Cliona celata. Organic Letters. 10: 2959-62. PMID 18553912 DOI: 10.1021/Ol800937U  0.725
2008 Nodwell M, Riffell JL, Roberge M, Andersen RJ. Synthesis of antimitotic analogs of the microtubule stabilizing sponge alkaloid ceratamine A. Organic Letters. 10: 1051-4. PMID 18278926 DOI: 10.1021/Ol7030284  0.75
2008 Hadaschik BA, Ettinger S, Sowery RD, Zoubeidi A, Andersen RJ, Roberge M, Gleave ME. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. International Journal of Cancer. Journal International Du Cancer. 122: 2368-76. PMID 18240145 DOI: 10.1002/Ijc.23406  0.327
2008 Sturgeon CM, Cinel B, Díaz-Marrero AR, McHardy LM, Ngo M, Andersen RJ, Roberge M. Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones. Cancer Chemotherapy and Pharmacology. 61: 407-13. PMID 17440726 DOI: 10.1007/S00280-007-0483-Y  0.801
2007 Williams DE, Keyzers RA, Warabi K, Desjardine K, Riffell JL, Roberge M, Andersen RJ. Spirastrellolides C to G: macrolides obtained from the marine sponge Spirastrella coccinea. The Journal of Organic Chemistry. 72: 9842-5. PMID 17988148 DOI: 10.1021/Jo7018174  0.75
2007 Williams DE, Sturgeon CM, Roberge M, Andersen RJ. Nigricanosides A and B, antimitotic glycolipids isolated from the green alga Avrainvillea nigricans collected in Dominica. Journal of the American Chemical Society. 129: 5822-3. PMID 17439220 DOI: 10.1021/Ja0715187  0.7
2007 Warabi K, Patrick BO, Austin P, Roskelley CD, Roberge M, Andersen RJ. Strongylophorine-26, an inhibitor of cancer cell Invasion: SAR revealed by synthesis of analogues. Journal of Natural Products. 70: 736-40. PMID 17407351 DOI: 10.1021/Np060481L  0.307
2007 Sturgeon CM, Roberge M. G2 checkpoint kinase inhibitors exert their radiosensitizing effects prior to the G2/M transition. Cell Cycle (Georgetown, Tex.). 6: 572-5. PMID 17351346  0.71
2007 Brastianos HC, Sturgeon CM, Roberge M, Andersen RJ. Inhibition of the G2 DNA damage checkpoint by oliveroline isolated from Duguetia odorata. Journal of Natural Products. 70: 287-8. PMID 17315964 DOI: 10.1021/Np060285E  0.719
2006 Rundle NT, Nelson J, Flory MR, Joseph J, Th'ng J, Aebersold R, Dasso M, Andersen RJ, Roberge M. An ent-kaurene that inhibits mitotic chromosome movement and binds the kinetochore protein ran-binding protein 2. Acs Chemical Biology. 1: 443-50. PMID 17168522 DOI: 10.1021/Cb600196W  0.762
2006 Sturgeon CM, Kemmer D, Anderson HJ, Roberge M. Yeast as a tool to uncover the cellular targets of drugs. Biotechnology Journal. 1: 289-98. PMID 16897709 DOI: 10.1002/biot.200500039  0.67
2006 Vottero E, Balgi A, Woods K, Tugendreich S, Melese T, Andersen RJ, Mauk AG, Roberge M. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast. Biotechnology Journal. 1: 282-8. PMID 16897708 DOI: 10.1002/Biot.200600001  0.379
2006 Sturgeon CM, Knight ZA, Shokat KM, Roberge M. Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Molecular Cancer Therapeutics. 5: 885-92. PMID 16648558 DOI: 10.1158/1535-7163.Mct-05-0358  0.711
2005 Sturgeon CM, Craig K, Brown C, Rundle NT, Andersen RJ, Roberge M. Modulation of the G2 cell cycle checkpoint by sesquiterpene lactones psilostachyins A and C isolated from the common ragweed Ambrosia artemisiifolia. Planta Medica. 71: 938-43. PMID 16254826 DOI: 10.1055/S-2005-873109  0.794
2005 McHardy LM, Warabi K, Andersen RJ, Roskelley CD, Roberge M. Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions. Molecular Cancer Therapeutics. 4: 772-8. PMID 15897241 DOI: 10.1158/1535-7163.Mct-04-0310  0.79
2005 Karjala G, Chan Q, Manzo E, Andersen RJ, Roberge M. Ceratamines, structurally simple microtubule-stabilizing antimitotic agents with unusual cellular effects. Cancer Research. 65: 3040-3. PMID 15833830 DOI: 10.1158/0008-5472.Can-04-4369  0.394
2004 Warabi K, McHardy LM, Matainaho L, Van Soest R, Roskelley CD, Roberge M, Andersen RJ. Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity. Journal of Natural Products. 67: 1387-9. PMID 15332859 DOI: 10.1021/Np0340246  0.767
2004 Baetz K, McHardy L, Gable K, Tarling T, Rebérioux D, Bryan J, Andersen RJ, Dunn T, Hieter P, Roberge M. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proceedings of the National Academy of Sciences of the United States of America. 101: 4525-30. PMID 15070751 DOI: 10.1073/Pnas.0307122101  0.778
2004 McHardy LM, Sinotte R, Troussard A, Sheldon C, Church J, Williams DE, Andersen RJ, Dedhar S, Roberge M, Roskelley CD. The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Research. 64: 1468-74. PMID 14973060 DOI: 10.1158/0008-5472.Can-03-2733  0.786
2004 Huang XH, van Soest R, Roberge M, Andersen RJ. Spiculoic acids A and B, new polyketides isolated from the Caribbean marine sponge Plakortis angulospiculatus. Organic Letters. 6: 75-8. PMID 14703354 DOI: 10.1021/Ol0361047  0.306
2003 Haggarty SJ, Koeller KM, Kau TR, Silver PA, Roberge M, Schreiber SL. Small molecule modulation of the human chromatid decatenation checkpoint. Chemistry & Biology. 10: 1267-79. PMID 14700634 DOI: 10.1016/J.Chembiol.2003.11.014  0.396
2003 Zhou BB, Anderson HJ, Roberge M. Targeting DNA checkpoint kinases in cancer therapy. Cancer Biology & Therapy. 2: S16-22. PMID 14508077 DOI: 10.4161/Cbt.200  0.347
2003 Britton R, Roberge M, Brown C, van Soest R, Andersen RJ. New okadaic acid analogues from the marine sponge Merriamum oxeato and their effect on mitosis. Journal of Natural Products. 66: 838-43. PMID 12828471 DOI: 10.1021/Np0300129  0.406
2003 Williams DE, Roberge M, Van Soest R, Andersen RJ. Spirastrellolide A, an antimitotic macrolide isolated from the Caribbean marine sponge Spirastrella coccinea. Journal of the American Chemical Society. 125: 5296-7. PMID 12720440 DOI: 10.1021/Ja0348602  0.357
2003 Nieman JA, Coleman JE, Wallace DJ, Piers E, Lim LY, Roberge M, Andersen RJ. Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues. Journal of Natural Products. 66: 183-99. PMID 12608848 DOI: 10.1021/Np020375T  0.34
2002 Williams DE, Craig KS, Patrick B, McHardy LM, van Soest R, Roberge M, Andersen RJ. Motuporamines, anti-invasion and anti-angiogenic alkaloids from the marine sponge Xestospongia exigua (Kirkpatrick): isolation, structure elucidation, analogue synthesis, and conformational analysis. The Journal of Organic Chemistry. 67: 245-58. PMID 11777468 DOI: 10.1021/Jo016101C  0.776
2001 Rundle NT, Xu L, Andersen RJ, Roberge M. G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin. The Journal of Biological Chemistry. 276: 48231-6. PMID 11572854 DOI: 10.1074/Jbc.M103990200  0.8
2001 Britton R, De Silva ED, Bigg CM, McHardy LM, Roberge M, Andersen RJ. Synthetic transformations of eleutherobin reveal new features of its microtubule-stabilizing pharmacophore [20] Journal of the American Chemical Society. 123: 8632-8633. PMID 11525686 DOI: 10.1021/Ja016459Q  0.762
2001 Curman D, Cinel B, Williams DE, Rundle N, Block WD, Goodarzi AA, Hutchins JR, Clarke PR, Zhou BB, Lees-Miller SP, Andersen RJ, Roberge M. Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. The Journal of Biological Chemistry. 276: 17914-9. PMID 11279124 DOI: 10.1074/Jbc.M100728200  0.8
2000 Jiang X, Lim LY, Daly JW, Li AH, Jacobson KA, Roberge M. Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs. International Journal of Oncology. 16: 971-8. PMID 10762633 DOI: 10.3892/Ijo.16.5.971  0.391
2000 Sauvé DM, Anderson HJ, Ray JM, James WM, Roberge M. Phosphorylation-induced rearrangement of the histone H3 NH2-terminal domain during mitotic chromosome condensation Journal of Cell Biology. 145: 225-235. PMID 10209020 DOI: 10.1083/Jcb.145.2.225  0.309
1998 Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM, Anderson H, Darzynkiewicz Z. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis Cytometry. 32: 71-77. PMID 9627219 DOI: 10.1002/(Sici)1097-0320(19980601)32:2<71::Aid-Cyto1>3.0.Co;2-H  0.359
1998 Anderson HJ, Jong Gd, Vincent I, Roberge M. Flow cytometry of mitotic cells. Experimental Cell Research. 238: 498-502. PMID 9473359 DOI: 10.1006/Excr.1997.3862  0.344
1998 Berlmck RGS, Britton R, Piers E, Lim L, Roberge M, Rosana Moreira Da Rocha, Andersen RJ. Granulatimide and isogranulatimide, aromatic alkaloids with G2 checkpoint inhibition activity isolated from the Brazilian ascidian Didemnum granulatum: Structure elucidation and synthesis Journal of Organic Chemistry. 63: 9850-9856. DOI: 10.1021/Jo981607P  0.411
1997 Anderson HJ, Coleman JE, Andersen RJ, Roberge M. Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemotherapy and Pharmacology. 39: 223-6. PMID 8996524 DOI: 10.1007/S002800050564  0.309
1995 Guo XW, Th'ng JP, Swank RA, Anderson HJ, Tudan C, Bradbury EM, Roberge M. Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation. The Embo Journal. 14: 976-85. PMID 7889943  0.78
1992 Roberge M. Checkpoint controls that couple mitosis to completion of DNA replication. Trends in Cell Biology. 2: 277-281. PMID 14731521 DOI: 10.1016/0962-8924(92)90201-W  0.365
1992 O'Neill TE, Roberge M, Bradbury EM. Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase. Journal of Molecular Biology. 223: 67-78. PMID 1731087 DOI: 10.1016/0022-2836(92)90716-W  0.758
1991 Roberge M, O'Neill TE, Bradbury EM. Inhibition of 5S RNA transcription in vitro by nucleosome cores with low or high levels of histone acetylation Febs Letters. 288: 215-218. PMID 1879554 DOI: 10.1016/0014-5793(91)81037-9  0.765
1990 Roberge M, Th'ng J, Hamaguchi J, Bradbury EM. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells Journal of Cell Biology. 111: 1753-1762. PMID 2172257  0.783
1988 Roberge M, Dahmus ME, Bradbury EM. Chromosomal loop/nuclear matrix organization of transcriptionally active and inactive RNA polymerases in HeLa nuclei Journal of Molecular Biology. 201: 545-555. PMID 3418709 DOI: 10.1016/0022-2836(88)90636-5  0.428
1988 Roberge M, Bradbury EM. RNA contacts the two large polymerase subunits and a 52-kDa polypeptide in nucleolar RNA polymerase I transcribing complexes Journal of Biological Chemistry. 263: 18553-18557. PMID 3192549  0.404
1986 Schaller HC, Roberge M, Zachmann B, Hoffmeister S, Schilling E, Bodenmüller H. The head activator is released from regenerating Hydra bound to a carrier molecule. The Embo Journal. 5: 1821-4. PMID 16453697  0.427
1984 Roberge M, Escher E, Schaller HC, Bodenmüller H. The hydra head activator in human blood circulation. Degradation of the synthetic peptide by plasma angiotensin-converting enzyme. Febs Letters. 173: 307-13. PMID 6086405 DOI: 10.1016/0014-5793(84)80796-6  0.426
Show low-probability matches.